Michael P Jones

Michael P Jones
Professor of Biostatistics, College of Public Health
Professor of Statistics and Actuarial Science, College of Liberal Arts and Sciences

Contact Information

Primary Office: N324 CPHB

Education

  • PhD in Biomathematics, University of Washington, Seattle, Washington, 1986
  • MA in Mathematics, University of California- Los Angeles, Los Angeles, California, 1975
  • BA in Mathematics, University of Southern California, Los Angeles, California, 1972

Areas of Research Interest

  • Analysis of left-censored data: Area of Research Interest
  • Causal inference: Area of Research Interest
  • Environmental health studies: Current Project
  • Health services research studies: Current Project
  • Likelihood theory: Area of Research Interest
  • Methods for informative dropout: Area of Research Interest
  • Nonparametrics: Area of Research Interest
  • Robust methods of regression: Area of Research Interest
  • Semiparametric regression: Area of Research Interest
  • Statistical methods for epidemiology: Area of Research Interest
  • Survival analysis: Area of Research Interest

Selected Publications

  • Ohl, M. E., Richardson, K., Rodriguez-Barradas, M. C., Bedimo, R., Marconi, V., Morano, J. P., Jones, M. P. & Vaughan Sarrazin, M. (In Press). Impact of availability of telehealth programs on documented HIV viral suppression: A cluster-randomzed program evalution in Veterans Health Administration. Open Forum Infectious Disease.
  • Lou, Y., Jones, M. P. & Sun, W. (2018). Estimation of causal effects in clinical endpoint bioequivalence studies in the presence of intercurrent events: Noncompliance and missing data. Journal of Biopharmaceutical Statistics, Published online July 11, 2018. DOI: https://www.tandfonline.com/doi/full/10.1080/10543.
  • Lou, E., Jones, M. P. & Sun, W. (In Press). Estimation of causal effects in clinical endpoint bioequivalence studies in the presence of intercurrent events: Noncompliance and missing data. Journal of Biopharmaceutical Statistics.
  • Smith, S., Jones, M. P., Dotson, M. M. & Wolinsky, F. D. (2018). Computerized cognitive training to improve mood in senior living settings: Design of a randomized controlled trial. Open Access Journal of Clinical Trials, 10, 29-41.
  • Roblin, D. W., Cram, P., Lou, Y., Edmonds, S. W., Hall, S. F., Jones, M. P., Saag, K. G., Wright, N. C., Wolinsky, F. D. & PAADRN Investigators, (2018). Diet and exercise changes following bone densitometry in the Patient Activation After DXA Result Notification (PAADRN) study. Archives of Osteoporosis, 13(1), 4. PMID: 29307094.
  • Wolinsky, F. D., Cram, P., Lou, Y., Edmonds, S. W., Hall, S. F., Jones, M. P., Wright, N. C., Saag, K. G. & Roblin, D. W. (2017). Activating patients with a tailored bone density test results letter and educational brochure: The PAADRN randomized controlled trial. Journal of Clinical Densitometry, 20(4), 464-471. PMID: 27647261.
  • Wolinsky, F. D., Hall, S. F., Lou, Y., Edmonds, S., Saag, K. G., Roblin, D. W., Wright, N. C., Jones, M. p., Cram, P., PAADRN Investigators,, Curtis, J. R., Morgan, S. L., Schlechte, J. A., Williams, J. H. & Zelman, D. J. (2017). The cost of a patient activation intervention for achieving successful outcomes: Results from the PAADRN randomized controlled trial. Osteoporosis International, 28(10), 3061-3066. PMID: 28620779.
  • Wolinsky, F. D., Lou, Y., Edmonds, S. W., Saag, K. G., Roblin, D. W., Wright, N. C., Jones, M. P., Cram, P. & PAADRN Investigators, (2017). The effects of a patient activation intervention on smoking and randomized controlled trial. Osteoporosis International, 28(10), 3055-3060. PMID: 28573377.
  • Mallakpour, I., Villarini, G., Jones, M. P. & Smith, J. A. (2017). On the use of Cox regression to examine the temporal clustering of flooding and heavy precipitation across the central United States. Global and Planetary Change, 155, 98-108.
  • Hall, S. F., Edmonds, S. W., Lou, Y., Cram, P., Roblin, D. W., Saag, K. G., Wright, N. C., Jones, M. P. & Wolinsky, F. D. (2017). Patient-reported reasons for nonadherence to recommended osteoporosis pharmacotherapy. Journal of the American Pharmacists Association, 57(4), 503-504. PMID: 28602783.
Last Modified Date: June 20, 2019